Log in

Your Resource for Neurotherapeutics Discovery and Development

  • Home
  • ASENT 2024 Clinical Trials Course Application

ASENT 2024 Clinical Trials Course Application

  • December 11, 2023
  • 11:30 PM
  • Hyatt Regency Bethesda, Bethesda MD


Training in Neurotherapeutic Clinical Trials: Development and Implementation Course



About the Course

ASENT is pleased to offer a 1½-day course March 11-12, 2024 at the Hyatt Regency Bethesda, in Bethesda, MD to introduce researchers and clinicians to the principles of neurotherapeutic clinical trial development and implementation. The course will be especially relevant if you are interested in conducting neurotherapeutic clinical trials.

The course covers the principles of clinical trials from pre-clinical programs to Phase III design and implementation, including necessary regulatory conversations and IND enabling studies, IRB oversight and adverse event tracking and reporting. The course considers clinical trials in the neurotherapeutic space for both drugs and devices. The course will also address the unique challenges inherent in developing treatments for nervous system disorders. 

The course will feature a mix of:

  • Didactic sessions that go in depth into a wide range of topics

  • Interactive workshops where participants will work in teams on projects such as drafting protocols and addressing adverse events 

  • Panel discussions with lively Q&A 

  • Networking dinners with industry leaders

  • Full access to the ASENT Annual Meeting


Participants who attend the course will have ongoing access to senior faculty in attendance in a mentoring capacity. We anticipate that most applicants will have some familiarity with clinical research or will have attended the Training in Neurotherapeutics Drug Discovery and Development course; however, any clinical investigator who would benefit from the course is invited to apply. Those in industry and in private practice are also welcome to apply. There is no tuition or registration fee for successful applicants in 2024. The course will be offered annually and participants have full access to the ASENT Annual Meeting.

You will be asked to provide:

  • Name
  • Contact Information
  • CV

We are excited to have the opportunity to offer this course, which we believe will help to advance the availability of new drugs for patients with neurological conditions. If your work would benefit from an understanding of neurologic clinical trials you are encouraged to apply.


Powered by Wild Apricot Membership Software